Contact Us

Veran Announces the Addition of Serrated Cup Forceps to Its Ever-Expanding Line of Always-On Tip Tracked Instruments

See all News

October 22, 2012 – Veran Medical Technologies

Veran  Medical  Technologies, developers  of  the  next generation of minimally invasive delivery of interventional oncology therapies, announced today at the CHEST 2012 Conference the latest expansion of the Always On Tip Tracked family of instrumentation. Veran’s Always On Tip Tracked instruments are used with the SPiN Drive electromagnetic navigation platform and include an array of brushes, needles, forceps and catheters with patented electromagnetic sensors at the tip for accurate navigating and sampling deep in the lungs. As a part of Veran’s total oncology solution, SPiN Drive technology allows physicians to biopsy Solitary Pulmonary Nodules (SPN’s) for the potential early diagnosis for lung cancer.

Read More

About Veran Medical Technologies

Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined.

Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System®. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States. Veran provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked® instruments and Veran’s exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists.

Another challenge lung specialists face is that approximately 40% of lung nodules lie outside of an airway, making them very difficult to reach endobronchially, and traditionally requiring an additional procedure. Veran’s SPiN Thoracic Navigation System® is the first and only FDA cleared technology that enables Pulmonologists or Thoracic Surgeons to safely and accurately access lung nodules outside of an airway using SPiN Perc®, a navigated transthoracic needle. With SPiN Perc®, Veran combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. The early diagnosis and treatment of lung cancer has been proven to save lives.

Media Inquiries: Please Contact

Contact Us